Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1
about
Evolution of distinct EGF domains with specific functionsNotch receptor-ligand binding and activation: insights from molecular studiesStructure of the C-terminal domains of merozoite surface protein-1 from Plasmodium knowlesi reveals a novel histidine binding siteThe structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine designPlasmodium cysteine repeat modular proteins 1-4: complex proteins with roles throughout the malaria parasite life cycleGenetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidatePlasmodium falciparum merozoite surface protein 8 is a ring-stage membrane protein that localizes to the parasitophorous vacuole of infected erythrocytes.Histidine affinity tags affect MSP1(42) structural stability and immunodominance in mice.Protection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responsesFormation of the food vacuole in Plasmodium falciparum: a potential role for the 19 kDa fragment of merozoite surface protein 1 (MSP1(19))Lineage-specific positive selection at the merozoite surface protein 1 (msp1) locus of Plasmodium vivax and related simian malaria parasites.The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.Plasmodium falciparum merozoite surface protein 1 (MSP-1)-MSP-3 chimeric protein: immunogenicity determined with human-compatible adjuvants and induction of protective immune response.Schistosomiasis coinfection in children influences acquired immune response against Plasmodium falciparum malaria antigensPlasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.Production and preclinical evaluation of Plasmodium falciparum MSP-119 and MSP-311 chimeric protein, PfMSP-Fu24Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria.Epitope mapping of PfCP-2.9, an asexual blood-stage vaccine candidate of Plasmodium falciparum.Functional analysis of proteins involved in Plasmodium falciparum merozoite invasion of red blood cells.A protective glycosylphosphatidylinositol-anchored membrane protein of Plasmodium yoelii trophozoites and merozoites contains two epidermal growth factor-like domains.Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.Different regions of the malaria merozoite surface protein 1 of Plasmodium chabaudi elicit distinct T-cell and antibody isotype responses.Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.Structural biology. Structural basis for Notch1 engagement of Delta-like 4New insights for native production of MSP1(19), the disulfide-rich C-terminal fragment from Plasmodium falciparum merozoite surface protein 1.Small molecule targeting malaria merozoite surface protein-1 (MSP-1) prevents host invasion of divergent plasmodial species.Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systemsPlasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.Proteases in host cell invasion by the malaria parasite.Redox-assisted protein folding systems in eukaryotic parasitesA new release on life: emerging concepts in proteolysis and parasite invasion.Tailoring subunit vaccine immunogenicity: maximizing antibody and T cell responses by using combinations of adenovirus, poxvirus and protein-adjuvant vaccines against Plasmodium falciparum MSP1.Antigenicity of a Bacterially Expressed Triple Chimeric Antigen of Plasmodium falciparum AARP, MSP-311 and MSP-119: PfAMSP-Fu35Malaria vaccines in development.Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.A robust neutralization test for Plasmodium falciparum malaria.Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine.Binding of calcium to anticoagulant protein S: role of the fourth EGF module
P2860
Q24644356-FF72084C-B27F-4703-9E53-1D8A7ADA7727Q27023341-6DFE9B1D-9FB8-46D2-A464-EDB1CCB3AE95Q27640198-BA4969DF-8782-47F4-805A-97D4FA14C276Q27681234-0B07444F-AFC1-4829-B98C-CD7753B0F675Q27974391-3BE4957D-F7A4-4552-A4B3-66F2612A8248Q28748331-E71C3F24-007D-4243-8839-104176F8E5DFQ30043111-704AECBF-8557-4FC4-8BA6-4282F2747C18Q30409373-CB66607B-29E3-4DEE-A531-0C812F1E8CE7Q33356029-5765C6BC-56FE-48C5-9AD9-3D9C96939E6DQ33366572-8AAAC855-5359-459F-905C-D638E7110094Q33532314-31B948E5-A881-4183-B627-B5434976EE02Q33558061-86FBBA65-CAA8-40B4-8AE8-C854D4465D3DQ33613937-235797F6-248C-4E09-809C-9F2F35A21E11Q33697651-894B93B0-59BC-4182-BE1B-865CB332C007Q33742070-16D2E024-8C5F-4B16-9EB3-0A11E6419375Q33743450-0CB7B42A-350C-4C25-948A-D4AC782A8406Q33772752-E3E389DC-6E36-4790-B271-800A969F2D53Q33905364-D766972B-138B-4E90-A3CD-BA6B55538501Q33957155-09A5A90D-D9BF-4780-BEFF-AFAFAE4ABCA5Q34004960-E022ECAA-629E-4D85-801E-DC29C5677E29Q34006332-9577A392-1151-41F6-A2E8-EA02749BB189Q34006785-A44C3D79-A3FF-4FA8-9ABE-04E96E892F6EQ34154429-4F892C6F-6A0D-4F0B-BA75-2E1BEDF5891EQ34463833-FDA6A6CE-FA2C-4144-A0E7-2DA973F914D4Q34602992-1282883A-DC73-47B6-96D4-EF6FE83E240CQ35102544-A9342687-46D8-4CE4-91A5-6B4E75DD67AEQ35212980-7D587851-BC46-45EC-B8DB-4FDE6995E86BQ35802357-DDE50D5F-69E5-4B94-A45B-A10F99D7A147Q35805390-F767D089-E141-4185-BDB7-30634B52AD4CQ35875731-D90815D1-BD43-4D76-AFA1-067CA8A83BE1Q36026832-FF94618A-2DAC-4E77-B1C4-CA17AC9A2AAAQ36063959-4806995D-D34D-49FD-803D-51C7E249B82FQ36114395-788AE14A-1EE5-4C66-B892-1BC4E2AB9987Q36178611-5272694F-547D-451E-98AB-6C889C2011ECQ36219634-07CBCA9A-DDB1-426B-A761-F93BC0663670Q36313955-39DE9211-4F0C-4243-A512-EF4F84F59D60Q36368911-DD5D59FC-6751-476F-B027-E36DCA6BC1DAQ36368933-0D83227F-4F79-4C9C-AE53-DA0C5A785722Q36412687-9A1980EE-E77E-411F-B8F2-53F1D16BF615Q36459370-9279B916-2275-418E-B4B6-198D2C3FFC8E
P2860
Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Solution structure of an EGF m ...... um merozoite surface protein 1
@ast
Solution structure of an EGF m ...... um merozoite surface protein 1
@en
Solution structure of an EGF m ...... um merozoite surface protein 1
@nl
type
label
Solution structure of an EGF m ...... um merozoite surface protein 1
@ast
Solution structure of an EGF m ...... um merozoite surface protein 1
@en
Solution structure of an EGF m ...... um merozoite surface protein 1
@nl
prefLabel
Solution structure of an EGF m ...... um merozoite surface protein 1
@ast
Solution structure of an EGF m ...... um merozoite surface protein 1
@en
Solution structure of an EGF m ...... um merozoite surface protein 1
@nl
P2093
P3181
P356
P1476
Solution structure of an EGF m ...... um merozoite surface protein 1
@en
P2093
A A Holder
B Birdsall
C Uthaipibull
M G Gradwell
P A Burghaus
T A Frenkiel
W D Morgan
P304
P3181
P356
10.1006/JMBI.1999.2753
P407
P577
1999-05-28T00:00:00Z